ArticleGenes2026
ABO and Amelogenin Determination by PCR, from Experimental Bloodstains and from Museum Specimens, Using a Non-Destructive Approach.
Article in Genes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
objectivesMuseum collections constitute valuable material for investigating a wide range of histological processes. This results from the historical selection of unusual and advanced disease cases by museum curators, which are rarely encountered in contemporary clinical practice due to advances in medicine. Ancient DNA plays a crucial role in phylogenetic studies, as well as in analyses of population genetics. However, many commonly used DNA extraction techniques involve partial degradation of samples prior to DNA isolation. The use of non-destructive methods may enable the recovery of DNA appropriate for downstream analyses. Non-destructive methods of DNA extraction for research purposes are a recent development and facilitate genetic analyses of museum collections. ABO and Amel are examples of applications of the proposed method, although any set of primers can be used. ABO genotyping has been widely used in phylogenetic and population analyses.
methodsThis study presents a non-destructive approach for PCR-based DNA extraction from preserved museum samples. Human tissue samples, filter materials used during preservation, and processed conservation fluids (after dilution and dialysis) were analyzed to determine ABO genotype and sex (based on Amelogenin).
resultsThe same replicable PCR profile (ABO blood group and sex determined by Amelogenin) was observed across all three sample types: tissues, filter papers, and conservation fluid. The use of a preservative solution is a new development, as it leaves the sample intact. However, this approach has a drawback: DNA diffuses into the preservative solution very slowly, and it takes several decades to reach a sufficient concentration. A major advantage of this approach is the ability to perform a PCR test without DNA preparation.
conclusionsMuseum-derived samples represent a reliable source of DNA and can be effectively used in PCR-based analyses. The presented method works well with degraded DNA samples, combining an already established very short Amelogenin amplicon with PCR sequence-specific primers for ABO genotyping.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.